Back
Nuveen S&P 500 Dynamic Overwrite Fund Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
76
SPXX
Nuveen S&P 500 Dynamic Overwrite Fund
Last Price:
16.48
Seasonality Move:
-0.39%
Buy
94
LBPH
Longboard Pharmaceuticals
Last Price:
31.81
Seasonality Move:
0.54%
Buy
76
Nuveen S&P 500 Dynamic Overwrite Fund (SPXX)
is a Buy
Is Nuveen S&P 500 Dynamic Overwrite Fund a Buy, Sell or Hold?
- The current Nuveen S&P 500 Dynamic Overwrite Fund [SPXX] share price is $16.49. The Score for SPXX is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- SPXX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
94
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $31.91. The Score for LBPH is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SPXX Stock Price Chart
What is Nuveen S&P 500 Dynamic Overwrite Fund's stock price today?
-
The Nuveen S&P 500 Dynamic Overwrite Fund share price today is $16.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPXX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $31.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
SPXX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 72.25 | Buy |
Chaikin Money Flow: | 21835 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.84 - 16.26) | Buy |
Bollinger Bands (100): | (15.32 - 15.96) | Buy |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.64 | Buy |
Relative Strength Index (14 RSI): | 83.82 | Buy |
Chaikin Money Flow: | -14813 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.72 - 25.2) | Buy |
Bollinger Bands (100): | (17.96 - 22.88) | Buy |
SPXX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.24 | Buy |
20-day SMA: | 16.12 | Buy |
50-day SMA: | 15.82 | Buy |
200-day SMA: | 15.18 | Buy |
8-day EMA: | 16.29 | Buy |
20-day EMA: | 16.13 | Buy |
50-day EMA: | 15.89 | Buy |
200-day EMA: | 15.49 | Buy |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.62 | Buy |
20-day SMA: | 21.6 | Buy |
50-day SMA: | 20.76 | Buy |
200-day SMA: | 15.19 | Buy |
8-day EMA: | 26.93 | Buy |
20-day EMA: | 23.33 | Buy |
50-day EMA: | 21.23 | Buy |
200-day EMA: | 16.56 | Buy |
Nuveen S&P 500 Dynamic Overwrite Fund Earnings Growth & SPXX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.56 per share, and a decrease next year of $0.55 per share.
Nuveen S&P 500 Dynamic Overwrite Fund Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |